Literature DB >> 11823516

Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.

Ganwei Lu1, Bratislav M Janjic, Jelena Janjic, Theresa L Whiteside, Walter J Storkus, Nikola L Vujanovic.   

Abstract

Our recent studies have demonstrated that human immature dendritic cells (DCs) are able to directly and effectively mediate apoptotic killing against a wide array of cultured and freshly-isolated cancer cells without harming normal cells. In the present study, we demonstrate that this tumoricidal activity is mediated by multiple cytotoxic TNF family ligands. We determine that human immature DCs express on their cell surface four different cytotoxic TNF family ligands: TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis inducing ligand; while cancer cells express the corresponding death receptors. Disruptions of interactions between the four ligands expressed on DCs and corresponding death-signaling receptors expressed on cancer cells using specific Abs or R:Fc fusion proteins block the cytotoxic activity of DCs directed against cancer cells. The novel findings suggest that DC killing of cancer cells is mediated by the concerted engagement of four TNF family ligands of DCs with corresponding death receptors of cancer cells. Overall, our data demonstrate that DCs are fully equipped for an efficient direct apoptotic killing of cancer cells and suggest that this mechanism may play a critical role in both afferent and efferent anti-tumor immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823516     DOI: 10.4049/jimmunol.168.4.1831

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism.

Authors:  Collin J LaCasse; Nona Janikashvili; Claire B Larmonier; Darya Alizadeh; Neale Hanke; Jessica Kartchner; Elaine Situ; Sara Centuori; Michael Har-Noy; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

2.  Strain-specific susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice.

Authors:  Haris G Vikis; Erin N Jackson; Alexander S Krupnick; Andrew Franklin; Andrew E Gelman; Qiong Chen; David Piwnica-Worms; Ming You
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.

Authors:  Jianping Pan; Minghui Zhang; Jianli Wang; Qingqing Wang; Dajing Xia; Wenji Sun; Lihuang Zhang; Hai Yu; Xuetao Cao
Journal:  J Cancer Res Clin Oncol       Date:  2005-02-12       Impact factor: 4.553

4.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Authors:  Tara M Kroll; Hemamalini Bommiasamy; Raymond E Boissy; Claudia Hernandez; Brian J Nickoloff; Ruben Mestril; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 5.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

6.  Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells.

Authors:  Andrea Sobo-Vujanovic; Stephan Munich; Nikola L Vujanovic
Journal:  Cell Immunol       Date:  2014-04-08       Impact factor: 4.868

7.  Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation.

Authors:  Xiaolin Hu; Mary A Zimmerman; Kankana Bardhan; Dafeng Yang; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Raphael Pollock; Dina Lev; Carl F Ware; Ellen Garber; Veronique Bailly; Jeffrey L Browning; Kebin Liu
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

8.  PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.

Authors:  Neale T Hanke; Collin J LaCasse; Claire B Larmonier; Darya Alizadeh; Malika Trad; Nona Janikashvili; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Eur J Immunol       Date:  2014-05-23       Impact factor: 5.532

Review 9.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

10.  CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling.

Authors:  Gudrun Strauss; Jonathan A Lindquist; Nathalie Arhel; Edward Felder; Sabine Karl; Tobias L Haas; Simone Fulda; Henning Walczak; Frank Kirchhoff; Klaus-Michael Debatin
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.